These findings establish DNASE1L3 as a key regulator of hepatic immune-metabolic homeostasis and suggest that its deficiency drives a pathological cascade involving pattern recognition receptor activation, endoplasmic reticulum stress, and ferroptosis, ultimately leading to non-alcoholic fatty liver disease (NAFLD). This evidence concerns the gene DNASE1L3 and metabolic dysfunction-associated steatotic liver disease.